Liothyronine (T₃) is the active thyroid hormone that works rapidly, whereas levothyroxine (T₄) is a pro-hormone requiring conversion to T₃. Liothyronine provides quicker symptom relief but has a shorter half-life, necessitating daily dosing.
Calcium can reduce liothyronine absorption if taken simultaneously. Separate the doses by at least four hours to ensure optimal bioavailability.
Both strengths deliver the same active molecule; the 25 mcg tablet provides a slightly higher dose, which may be needed for patients who do not achieve euthyroidism on 20 mcg. Dose adjustments are individualized.
Patients often notice improvement in energy levels and mood within 1-2 weeks, though full biochemical stabilization typically requires 4-6 weeks of therapy.
Carry the medication in its original labeled container, keep it with you in the cabin (not checked luggage), and bring a letter from your prescriber if you need to cross international borders.
Thyroid hormone can increase glucose absorption; diabetic patients may experience higher blood glucose readings and should monitor levels closely after dose changes.
Switching requires medical supervision because dosing equivalence is not linear, and abrupt changes can cause cardiac or metabolic instability.
Take the missed tablet as soon as you remember, provided there is at least a six-hour gap before the next scheduled dose. If it is near the next dose time, skip the missed one and continue with your regular schedule.
It can increase heart rate and myocardial oxygen demand; patients with recent cardiac events or uncontrolled arrhythmias should use it only when the benefit outweighs the risk and under close cardiology monitoring.
Some studies suggest liothyronine may augment antidepressant response, but the interaction is not pharmacokinetic. Any combined use should be managed by both an endocrinologist and a psychiatrist.
This article covers Liothyronine Sodium, available as a generic medication and marketed under brand names such as Cytomel. Liothyronine belongs to the thyroid-health therapeutic class and is supplied as an oral pill in strengths of 20 mcg and 25 mcg. In the United Kingdom it is a prescription-only medicine regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Liothyronine is a synthetic form of the active thyroid hormone triiodothyronine (T₃). After oral administration, the sodium salt is absorbed in the small intestine, entering the bloodstream where it binds to nuclear thyroid hormone receptors (TRα and TRβ) in target cells. Activation of these receptors modulates gene transcription, influencing basal metabolic rate, heat production, and the synthesis of proteins involved in cardiovascular, neurologic, and metabolic processes.
Key pharmacologic features include:
Liothyronine Sodium is MHRA-approved for the treatment of hypothyroidism in patients who cannot convert levothyroxine (T₄) to the active T₃ form, such as those with central hypothyroidism or after thyroidectomy. It may also be part of a combination regimen (e.g., Thyrolar) for certain cases of hypothyroidism where a single hormone does not achieve optimal control.
Typical patient populations include adults with confirmed low serum T₃ levels who require rapid hormonal replacement. Pediatric use is limited and must be guided by a pediatric endocrinologist.
Evidence from peer-reviewed studies suggests that liothyronine has been explored as an adjunctive therapy for major depressive disorder when standard antidepressants are insufficient. These investigations remain off-label in the UK and require individualized medical supervision.
Off-label use requires medical supervision and individualized risk assessment.
Who may benefit:
Absolute contraindications:
Relative contraindications:
Special populations:
These effects are usually dose-related and may improve with dose adjustment.
If any of these occur, seek immediate medical attention.
This article provides educational information about Liothyronine Sodium and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
